Chapter 40: Gastrointestinal and Antiemetic Drugs
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement, not replace, the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Imagine your body has, like, a second brain.
It has its own dedicated nervous system.
It produces more of the neurotransmitter serotonin than the brain inside your actual skull.
And it acts as this massive control center for your mood, your energy, and, you know, your immune system.
Yeah, it really is a profound shift in perspective.
Right.
And today on our deep dive, we aren't looking at the gray matter in your head.
We're looking at the hidden intelligence of your gut.
Which is so important because for a long time, human biology basically treated the gastrointestinal tract like simple plumbing.
You know, just a tube going from point A to point B.
If it leaks, you patch it.
Exactly.
If it's blocked, you clear it.
But once you dive into the pharmacology of the gut, you realize that that simple pipe is actually lined with millions of specialized sensors and complex chemical factories.
And that is our mission today.
We're taking a master class in the pharmacology of the gastrointestinal tract.
Specifically, we're translating chapter 40 of Lippincott Illustrated Reviews, pharmacology the seventh edition.
A fantastic, albeit dense chapter.
Very dense.
And if you are listening to this, maybe you're a college student prepping to master these concepts for your own studies.
And it is just incredibly easy to get overwhelmed by, you know, massive lists of drugs and side effects.
Oh, for sure.
The pure memorization route is brutal.
So we are throwing that away.
Yeah.
Instead, we're going to walk through this material in the exact order of the textbook, connecting the foundational physiology directly to the drug targets.
Right.
So we'll cover the six main GI conditions they focus on.
Peptic ulcers, GERD, chemotherapy -induced nausea and vomiting, or CINV, diarrhea, constipation, and finally, IBS and IBD.
By the end of this, the why behind the medicine is going to make perfect sense.
Okay, let's unpack this.
Let's start with the upper GI tract and a classic issue.
The acid problem.
Peptic ulcers.
Yes, the classic ulcer.
For decades, the cultural narrative was that ulcers were just a physical manifestation of like stressing out too much at your job.
Which is a narrative that fundamentally misunderstood the biology.
The root causes of peptic ulcer disease are largely physical and they're external.
Right.
It's not just the stress.
No.
The two overwhelming culprits are infection with a gram -negative bacteria called Helicobacter pylori and the heavy use of nonsteroidal anti -inflammatory drugs, you know, NSAIDs like ibuprofen.
If you look at figure 40 .2 in the text, it's actually quite striking.
It's this visual of a biopsy and you see this dense swarm of dark, rod -shaped H.
pylori bacteria just nestled deep into the protective gastric mucosa.
Yeah.
They are literally making a home right there in the stomach lining and diagnosing them doesn't even require an invasive biopsy anymore, which is great.
Oh, right.
The textbook has that diagram of the breath test, which is 40 .3, I think.
Yes, exactly.
The urea breath test.
The mechanism is fascinating.
The patient swallows a dose of urea that has been specially labeled with a specific measurable carbon isotope, carbon -13.
Okay.
So they drink the labeled urea.
Right.
Now, human cells don't rapidly break down urea in the stomach, but H.
pylori produces massive amounts of an enzyme called urease.
So the bacteria's urease essentially attacks that swallowed urea.
It hydrolyzes it and splits it apart into ammonia and labeled carbon dioxide.
Precisely.
That labeled carbon dioxide gets absorbed into the patient's bloodstream, travels up to the lungs, and they simply exhale it.
Wow.
So you just breathe it into a machine.
Yeah.
If the mass spectrometer detects that carbon -13 isotope in the breath, you have absolute proof that the bacteria is down there operating its chemical machinery.
So if it's a bacteria, we treat it like an infection, right?
Like sending in a strike team.
That's exactly how we treat it.
Eradicating H.
pylori is transformative.
It drops the recurrence rate of active ulcers from a staggering 60 to 100 percent per year, all the way down to less than 15 percent.
That is a massive drop.
It is, but it requires aggressive combination therapy.
The standard first -line approach is quadruple therapy.
You use bismuth subsalicylate to physically coat and disrupt the bacteria, plus two different antimicrobials.
Usually metronidazole and tetracycline, right?
Correct.
Those poison the bacteria's internal protein synthesis, and then you add a proton pump inhibitor, a PPI, to shut off the acid the stomach uses to inadvertently complicate the healing.
So it really is a highly coordinated siege.
Bismuth breaks the physical defenses, the antibiotics destroy the internal machinery, and the PPI changes the battlefield environment.
Exactly.
There's also a triple therapy, which is a PPI, amoxicillin, and clirithromycin, but that's really only for areas where the bacteria hasn't developed resistance to clirithromycin yet.
Okay, so that covers the bacterial invasion.
But we also have to address that battlefield environment itself.
The stomach acid.
Yes, shutting down the acid factory.
Understanding how the stomach actually manufactures that acid is totally a game changer for understanding the drugs.
Let's look at figure 40 .4, the cellular diagram of the parietal cell.
I love this diagram.
Imagine the cell membrane that faces the bloodstream.
Sitting on that membrane are three distinct chemical on switches.
Right, these are receptors for acetylcholine, histamine, and gastrin.
When any of those three molecules bind to their specific receptor, it kicks off an internal chain reaction.
It activates protein kinases inside the cell.
And those kinases eventually supply energy to the final piece of machinery on the opposite side of the cell, right?
The side facing the stomach cavity.
Yes.
That machine is the H plus K plus AT pace, commonly known as the proton pump.
It physically pumps hydrogen ions against a massive concentration gradient, dumping pure acid into the stomach.
The older generation of drugs tried to manage this by just blocking one of the on switches, the H2 receptor antagonists.
Exactly.
So if you see a drug ending in tidine,
like simidinine, famidine, or ranitidine, it competitively blocks that histamine switch.
You are essentially cutting off one of the three power supplies.
Which reduces acid secretion by about 70%.
It's significant, but the original drug in this class, simidinine, has largely fallen out of favor.
Because of the side effects, right?
The textbook visual for this, figure 40 .5, is pretty wild.
It is.
Simidinine's chemical structure causes unintended cross reactions.
It acts as a nonsteroidal antiandrogen.
It actually binds to and blocks testosterone receptors, while simultaneously inhibiting the body's ability to metabolize s -radial.
Wait, really?
So it's actively shifting the patient's hormonal balance?
Yes.
Which explains the specific endocrine side effects, like gynecomastia, the development of enlarged breast tissue in men, and galacteria, which is inappropriate milk production.
Wow.
And it messes with the liver too, doesn't it?
Oh, massively.
It creates a roadblock.
It binds strongly to the cytochrome P450 enzyme system in the liver.
And those enzymes metabolize dozens of other common medications.
Right.
So if you introduce simidinine, it occupies those liver enzymes, preventing them from breaking down other drugs.
Suddenly, a patient taking warfarin, a critical blood thinner or phenytoin for seizures, finds those drugs building up to highly toxic levels in their bloodstream.
Which perfectly explains why the pharmaceutical industry evolved to the next step.
I mean, why bother blocking just one hormonal switch and risking all those side effects when you can just pull the plug on the whole factory?
Exactly.
Bring in the proton pump inhibitors, the PPIs.
These are the drugs ending in liprazole, like ameprazole or pantoprazole.
The mechanism of a PPI is so elegant, they bypass those early membrane receptors entirely.
The drug diffuses into the highly acidic secretory canaliculi of the parietal cell.
And then they just don directly to the pump, right?
Yes.
They form a stable, covalent bond directly with the proton pump.
The drug physically welds the pump shut.
So you're inhibiting over 90 % of gastric acid.
But pulling the plug entirely has to cause collateral damage.
I mean, the stomach produces acid for a reason.
It does.
And if we look at figure 40 .6, the warning icon visual chronic suppression of that acid leads to severe consequences.
Stomach acid is required to strip calcium from our food.
So if you suppress the acid for a year or more, calcium absorption plummets.
Right, which increases the risk of bone fractures in the hip, wrist, and spine.
Furthermore, stomach acid is required to cleave vitamin B12 from dietary proteins.
Long -term PPI use predictably leads to B12 deficiency.
And we are drastically altering the microbiome, too.
If we raise the pH and make the stomach more hospitable, bad bacteria can survive the journey down into the intestines.
Leading to a significantly increased risk of Clostridium difficile, or C.
diff, as severe bacterial diarrhea.
We also have to watch out for cardiovascular interactions, particularly with omeprazole.
Yes, this is a critical textbook takeaway.
Omeprazole strongly inhibits a specific liver enzyme called CYP2C19.
The issue is that the antiplatelet drug clopidogrel requires that exact enzyme to convert from an inactive prodrug into its active form.
So if omeprazole is occupying the enzyme, the blood thinner simply never activates.
Leaving the patient totally vulnerable to a stroke or heart attack.
Ok, so if shutting down the acid factory comes with so many systemic risks, what if we just reinforce the walls?
We leave the acid alone and build better armor for the stomach lining.
The body already does this naturally using prostaglandins.
The stomach eucosa constantly produces prostaglandin E, which dials down acid production while stimulating protective mucus and bicarbonate.
It builds a neutralizing gel layer.
And the drug misoprostol is a synthetic analog that perfectly mimics this.
Exactly.
It specifically prevents the types of ulcers caused by NSAIDs, because NSAIDs actually work by depleting the body's natural prostaglandins.
But there is a crucial warning here.
Misoprostol is strictly contraindicated in pregnancy.
Strictly.
Prostaglandins stimulate smooth muscle contraction in the uterus.
Giving this drug to a pregnant patient will induce severe uterine contractions and result in a miscarriage.
Definitely a key study question takeaway for anyone listening.
Now what about just neutralizing the acid directly, like antacids?
Antacids are essentially basic chemistry experiments happening inside your stomach.
You introduce a weak base to react with the gastric acid.
But the specific elemental base you use dictates a totally different side effect profile.
Like, if you use aluminum hydroxide, it causes severe constipation.
But if you use magnesium hydroxide, it causes osmotic diarrhea.
So the pharmacological workaround is brilliantly simple.
You just combine them.
Right.
The aluminum -induced constipation and the magnesium -induced diarrhea physiologically cancel each other out, neutralizing the acid while maintaining completely normal bowel function.
I love that.
Now what about mucosal protective agents?
Like sucralpate.
I always visualize sucralpate as a liquid band -aid.
That's a great analogy.
When it hits the stomach, it polymerizes into this thick, sticky gel.
It physically binds to the exposed proteins of the ulcer, creating a barrier so the tissue can heal.
But there's a catch, right?
It requires an ascetic environment to work.
Absolutely.
It requires a low pH, so you cannot take it with PPIs, H2 blockers, or antacids.
If the stomach pH is too high, the liquid band -aid will never solidify, making the drug totally useless.
Okay, we've spent a lot of time on local stomach irritation.
Here's where it gets really interesting.
Let's pivot to systemic nausea, specifically chemotherapy -induced nausea and vomiting, or CINV.
The neural wiring for this is incredibly precise.
You have to visualize two specific sites in the brainstem.
First is the chemoreceptor trigger zone, the CTZ.
And the defining feature of the CTZ is that it sits outside the blood -brain barrier.
Yes.
It acts as an exposed chemical radar dish, constantly sampling the blood for circulating toxins like chemo drugs.
When it detects poison, it sends an electrical alarm to the vomiting center in the medulla.
Which acts as the physical command center to induce vomiting.
But there's a separate pathway from the gut, too.
Exactly.
When chemo damages the enterochromophin cells lining the gut, those ruptured cells dump massive amounts of serotonin.
And that serotonin travels up the vagus nerve, straight to the medulla.
Like a massive fiber optic cable, triggering the vomiting reflex before the toxin even reaches the brain's radar.
To stop it, we have to cut those specific wires.
Looking at the endometriic arsenal in figures 40 .9 and 40 .7, we have the phenothiazines, like prochlorparazine.
They block dopamine directly in the brain's CTZ radar.
Then we have the 5 -HT3 receptor blockers, recognized by the suffix cetron, like ondansetron or polonacetron.
These block serotonin in both the gut and the CTZ.
But the text notes a vital cardiac distinction between them.
Yes.
High doses of ondansetron, or dolastron, can block potassium channels in the heart, leading to QT prolongation, which is a dangerous heart arrhythmia.
But polonacetron is best for cardiac patients, because it doesn't carry that same risk.
Right.
We also have substituted benzamides, like metaclopramide.
It blocks dopamine in the CTZ.
But wait, blocking dopamine pathways in the brain carries a severe neurological risk, right?
I mean, doesn't that mess with physical movement?
It absolutely does.
Metaclopramide frequently causes extra pyramidal symptoms, or EPS.
Involuntary facial grimaces, severe muscle spasms, and this debilitating inner restlessness.
It's a major red flag.
They're also substance P or NK1 antagonists, like the reputin, right?
Yeah, those target the delayed phase of vomiting, like 24 plus hours after chemo.
But they have complex CYP3A4 interactions in the liver.
We also use benzodiazepines, like lorazepam, for anticipatory vomiting, and corticosteroids, like decomethazone, in combos.
The power of combinations is huge.
Figure 40 .10 has this bar chart visual.
Using one drug is okay, but combining dexamethasone with ondansetron yields a massive 91 % response rate against highly -emitogenic drugs like cisplatin.
The synergy is just undeniable.
Okay, let's move further down the track into the intestines.
How do we fix the speed of transit when things are moving too fast or too slow?
Let's talk diarrhea and constipation.
Diarrhea is ultimately a failure of transit time.
If the peristalsis is moving everything through too quickly, the fluid remains in the stool.
Our most effective antidiarrheals are lopramide and diphenoxylate.
So they're like opioid cousins that forgot how to kill pain but remembered how to stop the gut.
That is exactly what they are.
They act on presynaptic opioid receptors strictly within the enteric nervous system to halt peristalsis.
But they don't cross the blood -brain barrier.
Right, no euphoric high.
But there is a warning.
Because they bring gut motility to a screeching halt, you cannot use them in young kids or patients with severe colitis.
Because halting transit in an inflamed bowel can lead to toxic megacolon, right, where it dangerously expands and risks perforation.
Exactly.
Now on the flip side, we have laxatives for constipation.
Stimulants like bisacodal directly irritate nerve fibers in the colon.
And there's castor oil, which it's broken down and severely irritates the mucosa.
But, just like mesoprostol, it must be completely avoided in pregnancy.
Yes, that severe systemic irritation can easily stimulate premature uterine contractions.
A much more elegant approach seems to be the chloride channel activators, like lubiprostone.
Lubiprostone is great.
It selectively activates chloride channels, pumping chloride ions into the intestinal lumen.
Sodium follows the chloride, and water follows the sodium via osmosis.
So it naturally lubricates and expands the passage without causing the harsh cramping
Right, and no physiological tolerance either.
Sometimes motility issues aren't just temporary, though.
They are chronic syndromes.
Let's look at irritable bowel syndrome, IBS, and inflammatory bowel disease, IBD.
With IBS, the structure is normal, but the function is erratic.
So we quickly differentiate treatments based on symptoms.
Like linucleotide or lubiprostone for IBSC, the constipation variant.
And allostrinon or eluxidoline for IBSD, the diarrhea variant.
We also use dicyclamine to target the painful spasms for both types.
But IBD, which includes Crohn's and ulcerative colitis, is an autoimmune war zone.
The patient's immune system is actively destroying the intestines.
The heavy hitters here are the five amino salicylates, or five ASAs, like sulfasalazine and mesalamine.
They are topical anti -inflammatories.
But the textbook highlights sulfasalazine's unique side effects.
It's linked to a carrier molecule that causes hemolytic anemia and even male fertility issues, Yes, and it actively inhibits the intestinal absorption of dietary folate, so patients absolutely need folate supplementation.
The newer five ASAs drop that toxic carrier and use pH -dependent coatings to reach the colon.
But there's a vital warning there, too.
Yes, if you give a patient a PPI, it artificially raises the stomach pH.
The highly engineered five ASA pill gets confused, senses the neutral pH, and dissolves prematurely in the stomach, completely ruining the targeted effect.
When topical agents fail, we use corticosteroids.
But I thought a high first pass metabolism means a drug gets destroyed by the liver before it works.
Usually, yes.
But with the corticosteroid bootsenide, that rapid destruction is exactly what we want.
We want the potent steroid effect locally in the gut, but the moment it's absorbed into the blood, the liver instantly metabolizes it.
So it acts locally without massive systemic steroid side effects.
That's brilliant.
Finally, for severe IBD, we have biologics and immunomodulators.
Phetalizumab is a fascinating biologic.
It specifically blocks alpha -4 integrins.
Those are the adhesion molecules white blood cells use to invade the gut tissue, right?
Exactly.
It basically locks the door to the intestines, stopping the inflammation.
We also use eustechinumab and immunomodulators like methotrexate or theoprenes, such as azathioprine.
But those suppress cell division indiscriminately, right?
Yes.
Which leads to strict requirements for liver and blood count monitoring due to the severe risk of bone marrow suppression.
Wow.
If we step back and look at the sheer biological density of what we've covered, there is a fascinating underlying theme here.
The GI tract isn't just a simple plumbing tube.
Not at all.
From the specialized receptors of the parietal cells to the opioid receptors of the intestines.
And the vagal nerves acting as a highway straight to the brain's vomiting center.
The gut truly acts as a highly sensitive second brain that requires incredibly precise pharmacological targeting.
It demands to be treated with a precise scalpel rather than a sledgehammer.
To you the listener, we hope this systematic journey through the physiology and drug targets made this dense textbook material finally click into place.
Understanding how these intricate cellular machines work means you can actually predict side effects instead of just memorizing them.
Thank you for taking this deep dive with us today.
On behalf of our whole team here, next time you reach for a simple antacid, remember just how complex your inner chemical factory really is.
Stay curious, keep asking why, and we'll catch you on the next deep dive.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Pharmacological Treatment of Gastrointestinal DisordersBrenner and Stevens’ Pharmacology
- Evaluation and Management of Gastrointestinal DisordersPrimary Care: Interprofessional Collaborative Practice
- GastroenterologyA Comprehensive Review for the Certification and Recertification Examinations for Physician Assistants
- Adult Gastrointestinal MedicationsSaunders Comprehensive Review for the NCLEX-RN® Examination
- Disorders of Gastrointestinal FunctionPorth's Essentials of Pathophysiology
- Gastrointestinal Disorder Drug TherapyPharmacology: A Patient-Centered Nursing Process Approach